The 2025 ATS community-acquired pneumonia guideline, published in a 2026 journal issue, conditionally suggests fewer than 5 days of antibiotics, with a minimum of 3 days, for adults with outpatient CAP who reach clinical stability. The key point for clinicians: shorter treatment is an individualized stop decision after effective therapy and recovery, not an automatic 3-day prescription.

Why It Matters To Your Practice

• This approach could reduce unnecessary antibiotic exposure once patients improve, but the recommendation is based on low-quality evidence.

• The guidance applies to immunocompetent adults treated as outpatients and does not extend to immunocompromised patients, where the source material says it should not be applied as written.

Clinical Implications

• Before stopping at 3 or 4 days, document at least 3 days of effective antibiotic treatment, an improving clinical course, and no unresolved pneumonia-related instability.

• Commonly used stability criteria summarized in the ATS guideline include temperature 37.8 C or lower, heart rate under 100/min, respiratory rate under 24/min, systolic blood pressure 90 mmHg or higher, baseline mental status, and adequate oral intake, plus oxygen saturation at least 90% on room air or return to the patient’s baseline oxygen requirement if chronic hypoxemia is present, with the oxygen device or flow documented clearly and assessed under similar conditions to baseline; a return to baseline should not be inferred if substantially more oxygen than usual is needed, and prescribed oxygen should not be removed simply to obtain a room-air reading. For patients at risk of hypercapnic respiratory failure, the source notes that 88% to 92% is commonly used during acute illness while blood-gas results and clinical assessment guide care, but not as a universal target for all chronic hypoxemia.

Insights

• The guideline specifically advises reassessment, rather than stopping on a predetermined day, if symptoms worsen or if there is no meaningful improvement within about 48 to 72 hours.

• Longer or pathogen-specific courses may still be needed for complications such as empyema or lung abscess, pathogens that require longer treatment, substantial underlying lung disease, or when reliable follow-up is difficult to ensure. Chronic respiratory insufficiency is also an evidence gap because key short-course studies excluded these patients, so confidence in a 3- or 4-day course is lower.

The Bottom Line

• For stable outpatient CAP, the ATS guidance supports considering a 3- or 4-day course only after effective treatment and documented recovery.

• Use stability criteria to support judgment, not to trigger an automatic stop, and pair any short course with clear follow-up and contingency planning.

References:

Oral Antibiotics Show Similar Efficacy for Community-Acquired Pneumonia

Community-Acquired Pneumonia – NEET-PG

How birds can quietly spread a severe form of pneumonia